IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jabs, D. A.
Right arrow Articles by Prendergast, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jabs, D. A.
Right arrow Articles by Prendergast, R. A.
(Investigative Ophthalmology and Visual Science. 2001;42:399-401.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

The Role of Fas-Fas Ligand–Mediated Apoptosis in Autoimmune Lacrimal Gland Disease in MRL/MpJ Mice

Douglas A. Jabs1,2, Bella Lee1, Judith Whittum-Hudson3 and Robert A. Prendergast1

1 From the Departments of Ophthalmology and 2 Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and the 3 Department of Medicine, Wayne State University School of Medicine, Detroit, Michigan.

PURPOSE. MRL/MpJ mice spontaneously develop lacrimal gland inflammation and are a model for the human disorder Sjögren’s syndrome. MRL/MpJ-lpr/lpr (MRL/lpr) and MRL/Mp-+/+ (MRL/+) mice are congenic substrains, which differ only by a single autosomal recessive gene, the lpr mutation. This mutation results in defective Fas protein, defective lymphocytic apoptosis, and accelerated autoimmune lacrimal gland disease in MRL/lpr mice. We evaluated apoptosis in the lacrimal glands of MRL/lpr and MRL/+ mice.

METHODS. Inflammatory cells in the lacrimal glands of MRL/lpr and MRL/+ mice were evaluated for apoptosis with TUNEL staining and Fas and Fas ligand expression with immunohistochemistry.

RESULTS. MRL/lpr mice had a greater percentage of the lacrimal gland replaced by inflammatory infiltrate (30.3% ± 7.0%) than did MRL/+ mice (13.0% ± 3.0%, P = 0.02). However, similar amounts of lymphocytic apoptosis were present in the lacrimal glands of MRL/lpr and MRL/+ mice. The mean number of apoptotic cells per unit area of inflammation was 23.8 ± 2.4 in MRL/lpr mice and 24.6 ± 6.0 in MRL/+ mice (P = 0.91). Fas expression was absent on lymphocytes in MRL/lpr mice but was present on lymphocytes in MRL/+ mice. Fas ligand expression was present on epithelial structures in both substrains.

CONCLUSIONS. The accelerated lacrimal gland disease inflammation in MRL/lpr mice does not appear to be due to decreased apoptosis in the microenvironment of the lacrimal gland of MRL/lpr mice. It appears that in MRL/lpr mice there is defective extrathymic lymphoid apoptosis, permitting a relatively greater expansion of autoreactive T cells, which subsequently invade the lacrimal gland.




This article has been cited by other articles:


Home page
IOVSHome page
D. S. Vinay, J. D. Kim, T. Asai, B. K. Choi, and B. S. Kwon
Absence of 4 1BB Gene Function Exacerbates Lacrimal Gland Inflammation in Autoimmune-Prone MRL-Faslpr Mice
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4608 - 4615.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Barabino and M. R. Dana
Animal Models of Dry Eye: A Critical Assessment of Opportunities and Limitations
Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1641 - 1646.
[Full Text] [PDF]


Home page
IOVSHome page
E. K. Akpek, D. A. Jabs, H. C. Gerard, R. A. Prendergast, A. P. Hudson, B. Lee, and J. A. Whittum-Hudson
Chemokines in Autoimmune Lacrimal Gland Disease in MRL/MpJ Mice
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 185 - 190.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology